Displaying 1 - 9 of 9

Display:

12 24 48

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Metabolism, Alcohol & Toxicity

5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View

Metabolism, Alcohol & Toxicity

5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View

Metabolism, Alcohol & Toxicity

5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View

Metabolism, Alcohol & Toxicity

5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View

Displaying 1 - 9 of 9

Display:

12 24 48